Companies›Healthcare›Healthcare›Healthcare Services
NSE:ARTEMISMED

ARTEMIS MED SERVICE LTD

Healthcare › Healthcare Services
₹299.00
at close · 28 Oct 2026
▼ 0.50 (-0.17%)

Latest filings

Next results: Fri, 30 Oct · Financial Results
  1. Artemis Medicare schedules Q2 and H1 FY27 earnings call · Board & Shareholder Meetings
  2. Board to approve September 2026 quarterly and half-year results · Results
  3. Reg 74(5) Compliance Certificate for Quarter Ended Sep 30 2026 · Compliance
All filings ↓
Ask Nexa about ARTEMIS MED SERVICE LTD

Snapshot

What the business is, and whether it's a good one at a fair price.

AI · written from filings

Runs a chain of multi-specialty hospitals anchored by a flagship facility in Gurugram, with a 300-bed facility in Raipur commenced in July 2026 and a 650-bed South Delhi project (VIMHANS) targeted for FY29, aiming for 2,000+ beds across the network by 2029. In FY26, consolidated revenue was ₹1,081 crores (+15.4% YoY) with EBITDA margin of 20.2% and PAT of ₹104 crores (+26.2%). The Gurugram flagship posted an ARPOB of ₹84,571 and 64.6% occupancy in Q4 FY26, with management targeting 70%+ occupancy to unlock an additional 100 beds under a Platinum Green Building certification that requires no incremental land cost. Roughly 30% of revenue comes from international patients, whose ARPOB is around 1.3x the domestic figure, with management guiding to a 15% pricing hike in FY27 for both segments. The cost stack is dominated by other operating expenses at 43.8% of revenue, followed by materials (consumables, implants, pharmacy) at 23.5% and employee costs at 15.4%. New projects under ramp-up are expected to weigh on FY27 margins, with Raipur alone projected to book a loss of ₹18–20 crore before reaching breakeven at 18 months.

Operating scale
Gurugram ARPOB
₹84,571Q4 FY26
Gurugram occupancy
64.6%Q4 FY26
International patient revenue share
30% of totalFY26
Raipur facility
300 bedsCommenced July 9, 2026
VIMHANS South Delhi facility
650 beds, ₹500 crore capex (₹75–80 lakh per bed)Targeted FY29
Targeted bed capacity
2,000+ beds across networkBy 2029
Who pays it
Domestic and international patients seeking tertiary and quaternary multi-specialty care, including medical value travel patients from the Middle East, Africa and CIS; also serves insured patients under CGHS and insurance/insurer networks.
Biggest cost
Other operating expenses (43.8% of revenue), followed by materials and consumables (23.5%) and employee costs (15.4%).
Kind of business
Asset-heavy, multi-specialty hospital operator with high-margin flagship and expansion-driven ramp-up phase.
Where it sits
Apollo Tyres Group–backed hospital chain headquartered around its Gurugram flagship, expanding footprint into Central India (Raipur) and South Delhi with a stated target of 2,000+ beds by 2029.
Market Cap
₹4,733 Cr
P / E (TTM)
41.6×
EV / EBITDA
21.6×
Div Yield
0.13%
Growth
21.5%▲
Revenue 5y CAGR
PAT +75.9% · EBITDA +38.6%
Quality
12.2%▲
ROCE (5y median)
ROE 9.7% (5y median) · margin 19.9%
Leverage
0.24·
Debt / Equity · low
Net debt ₹193 Cr
Revenue FY21→FY26
2.6×▲
Margin +8.1 pts
₹408 Cr → ₹1,081 Cr
Cash conversion
1.88×▲
Operating cash ÷ profit · 5 yrs
₹573 Cr on ₹304 Cr
Moves on a normal day
1.33%·
Median daily move
Last 268 sessions · the yardstick for filing-day moves
Where it sits among 29 Hospital peersBar = share of peers beaten · tick = industry median · latest reported figures
P/E (TTM)#15/30
P/B#10/24
ROCE#14/30
ROE#14/24
Debt / Equity#13/24
EBITDA margin#15/24
Revenue growth#18/23
Profit growth#4/21

Scorecard

Measured from the filed financials, judged against its Hospital peers · as of FY26 — not investment advice

Strengths
Revenue compounding 22% a year over 5 years
Profit compounding 76% a year over 5 years
Profit grew in every one of the last 5 years
Over 5 years it reported ₹304 Cr of profit and ₹573 Cr of operating cash — 1.88×
Profit is converting into cash
Concerns
EPS grew slower than profit — the share count rose (bonus or dilution)

Charts

How has the market priced it — with filings on the timeline?

ARTEMISMED · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Peers

How does it stack up on valuation, returns and growth?

Loading peers…

Financials

Quarterly & annual P&L, balance sheet, cash flow, ratios and segments.

Loading financials…

Ownership

Who owns it — and is the promoter stake clean?

Loading shareholding…

Sign up to see the full company file

Governance, sustainability, compliance, earnings calls, presentations, events, reactions and the full filings feed — free with an account.

Common questions

Answered from ARTEMIS MED SERVICE LTD's filed financials and exchange disclosures

What does ARTEMIS MED SERVICE LTD do?

ARTEMIS MED SERVICE LTD is a Healthcare Services company listed on NSE and BSE, trading under the symbol ARTEMISMED.

Is ARTEMIS MED SERVICE LTD profitable?

Yes. Over the trailing twelve months ARTEMIS MED SERVICE LTD reported a net profit of ₹114 Cr on revenue of ₹1,114 Cr.

Does ARTEMIS MED SERVICE LTD pay a dividend?

Yes. The dividend yield is 0.13% at the current price. It paid out 6% of its profit as dividend in FY26.

Is ARTEMIS MED SERVICE LTD debt-free?

No. It reported borrowings of ₹227 Cr on its 31 Mar 2026 balance sheet, or net debt of ₹193 Cr after cash. Debt stands at 0.24× equity. That is higher than 52% of its 24 Hospital peers.

Is ARTEMIS MED SERVICE LTD expensive compared with its peers?

On trailing P/E, ARTEMIS MED SERVICE LTD ranks 15 of 30 in Hospital — cheaper than 52% of them, against an industry median of 42.0×. This is a position, not a valuation judgement.

How much does the ARTEMIS MED SERVICE LTD share price move in a day?

On a typical session ARTEMIS MED SERVICE LTD moves 1.33% — that is the median absolute close-to-close move across its last 268 trading days. MarketPing measures each filing's price reaction against it.

When are ARTEMIS MED SERVICE LTD's next results?

Financial Results on Fri, 30 Oct. MarketPing alerts you on WhatsApp the moment the filing lands.

Where can I track ARTEMIS MED SERVICE LTD's announcements?

Every NSE and BSE filing by ARTEMIS MED SERVICE LTD appears on this page, AI-summarised, alongside the price reaction that followed it. Follow the company to get each new filing on WhatsApp within minutes.

Figures are as last reported and may lag the latest filing. Not investment advice.